Bausch Health Companies | VRX - Loan Capital


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Bausch Health Companies

Bausch Health Companies Inc reported $20.21B in Loan Capital for its fiscal quarter ending in March of 2023.


Loan Capital Change
Amgen AMGN:US USD 60.76B 23.41B
ANI Pharmaceuticals ANIP:US USD 285.46M 212K
Bausch Health Companies Inc VRX:CN USD 20.21B 127M
Biogen BIIB:US USD 6.28B 1.7M
Catalent CTLT:US USD 4.22B 123M
Danaher DHR:US USD 18.26B 825M
Drreddys Laboratories RDY:US INR 1.28B 179M
Eli Lilly LLY:US USD 18.88B 4.14B
Endo International ENDP:US USD 7.69B 7.69B
Horizon Pharma HZNP:US USD 2.54B 2.61M
Pacira PCRX:US USD 542.92M 112.9M
Perrigo PRGO:US USD 4.06B 7.6M
Phibro Animal Health PAHC:US USD 466.02M 5.21M
Revance Therapeutics RVNC:US USD 379.86M 485K
Vertex Pharmaceuticals VRTX:US USD 417.6M 13.2M
Zoetis ZTS:US USD 6.56B 7M